Caricamento quotazioni...
Previsioni
| Acquista |
1 |
| Mantieni |
0 |
| Vendi |
0 |
Notizie Vai al feed delle notizie
Dominari Holdings changes terms for Series A warrants and offers reduced exercise price
Dominari Holdings agreed incentive arrangements with holders of Series A warrants and is offering two options: exercise all warrants by September 11, 2026 at a reduced price of $2.20 per share, or exchange unexercised warrants for common shares at a ratio of 1 share for every 5 underlying warrants. If holders choose option A, the company expects gross proceeds of about $2.9 million; under option B approximately 115,000 exchange shares would be issued. After the transactions, about 1.2 million Series A warrants would likely remain outstanding; the potential shares are registered for resale in an effective registration statement, while exchange shares are subject to an exemption. » Altro su de.investing.com
Dominari Holdings: stock rose by around 400% in 2025, strong capital-markets activity
Dominari Holdings recorded a price gain of about 400% in 2025 (from roughly $1.00 to almost $5.00) and is currently trading at approximately $4.19. The company paid dividends of around $22.2 million in 2025, generated revenue of $99.59 million (+691% YoY) and shows a very low P/E ratio of 0.46 and a price‑to‑book of 0.32. Dominari Securities completed numerous transactions, raised nearly $2 billion in capital (including leading roles in issuances) and strengthened liquidity with a current ratio of 4.74, indicating robust financial metrics and further upside potential. » Altro su de.investing.com
Dominari Holdings announces $10 million special dividend
Dominari Holdings will pay a cash special dividend of about $10 million (approximately $0.44 per share), payable around January 23, 2026 to shareholders of record at the close of trading on December 31, 2025. The micro‑cap company, with a market capitalization of roughly $67 million, is unusually issuing a special dividend for the first time despite the stock’s strong rise in 2025. Dominari reports a solid liquidity position (current ratio 4.74) and held about $176.2 million in cash and marketable securities as of September 30, 2025; a previously filed $2 billion shelf registration was withdrawn. Tim Ledwick was also appointed CFO, and the company is pursuing growth opportunities in areas such as AI and data centers. » Altro su de.investing.com
Dividendi storici Dividendi
Tutte le metriche sui dividendi Tutte le metricheDati finanziari dell'azienda
| (EUR) | giugno 2026 | YoY |
|---|---|---|
| Ricavi | 14,71 Mln | 49,15% |
| Utile lordo | 14,71 Mln | 49,15% |
| Utile netto | -4,36 Mln | 130,96% |
| EBITDA | -2,05 Mln | 87,45% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 37,38 Mln € |
Numero di azioni | 24,24 Mln |
Massimo/minimo a 52 settimane | 5,48 € - 1,53 € |
Rendimento da dividendo | 65,36% |
Dividendi TTM | 1,01 € |
Beta | 0,88 |
Rapporto P/E | -0,49 |
Rapporto PEG | 0,00 |
Rapporto P/B | 1,80 |
Rapporto P/S | 0,31 |
Profilo aziendale
Dominari Holdings Inc., una società di biotecnologie, si concentra sullo sviluppo di terapie antitumorali a piccola molecola. La pipeline di terapie della società comprende trattamenti per il cancro alla prostata, il cancro al pancreas, la leucemia mieloide acuta (AML) e la leucemia linfoblastica acuta. Sta sviluppando DHA-dFdC, un candidato farmaco per il pancreas, e KPC34, un trattamento a piccola molecola per la leucemia mieloide acuta e la leucemia linfoblastica acuta. La società sta inoltre sviluppando una piattaforma antivirale che inibisce la replicazione di virus, tra cui il virus dell'influenza, l'Ebolavirus e il virus di Marburg, SARS-CoV, MERS-CoV e SARS-CoV-2. Ha accordi di licenza con la University of Texas, la University of Maryland Baltimore, Silo Pharma Inc. e Wake Forest University Health Sciences. La società era precedentemente nota come AIkido Pharma Inc. e ha cambiato il proprio nome in Dominari Holdings Inc. nel dicembre 2022. Dominari Holdings Inc. è stata fondata nel 1967 e ha sede a New York, New York.
| Nome | Dominari Holdings |
| CEO | Anthony C. Hayes |
| Sede centrale | New York City,
ny Stati Uniti |
| Sito web | |
| Settore | Finanza |
| Industria | Servizi finanziari |
| Quotazione in borsa | 18/03/1980 |
| Dipendenti | 36 |
Deep Dive
Simboli di borsa
| Borsa | Simbolo |
|---|---|
NASDAQ | DOMH |
Frankfurt | BP2A.F |
Düsseldorf | BP2A.DU |